Skip to main content
Premium Trial:

Request an Annual Quote

BioDot to Co-market Quantiscientifics Microarray System

NEW YORK (GenomeWeb News) – Privately held Quantiscientifics today said that BioDot will co-market and sell its A2 MicroArray System.

The A2 system allows for multiplexing in a 96-well plate format. The system was initially developed at Beckman Coulter and enables multiplexing of antibodies, peptides, antigens, and biomarkers.

Irvine, Calif.-based Quantiscientifics said that key applications for the system include multiplex ELISAs for cytokine detection, allergy testing, autoimmune disease, vaccines, and biomarker validation.

BioDot, also based in Irvine, sells products for the research and diagnostics markets including biochips, biosensors, lateral flow immunoassays, and liquid despensers.

Financial and others terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.